Company announcements · 19/10/20261 min read

Inserted Launches BRINSUPRI® Tablets 25 mg (brensocatib hydrate) for the treatment of non- cystic fibrosis bronchiectasis in Japan

BRINSUPRI, a first-in-class and first-in-class treatment for patients with non-cystic fibrosis bronchiectasis (NCFB), is now available by prescription in Japan.